News and Events
News and Events
June 13, 2022
New Method for Cell Sorting Utilizing microRNA Switch and Magnetic Microbeads
The research group previously developed a technology, the microRNA (miRNA) switch, which is designed to suppress the expression of proteins encoded by artificial messenger RNA (mRNA) in response to miRNA in cells. (CiRA News: May 22, 2015). This technology made it possible to detect and sort cardiomyocytes and other cells not by surface receptors but by miRNAs. It is also a highly safe technique because there is no risk of damaging the genome, and the miRNA switches introduced into the cell only exist for a short period of time.
In this study, by combining the miRNA switch with a cell sorting method using magnetic microbeads (Magnetic-activated cell sorting; MACS), the research group succeeded in collecting and purifying large amounts of iPS cell-derived cardiomyocytes in the order of hundreds of millions in a short time and with high purity (>97%). When the cardiomyocytes collected using the new technology, the miR-switch-MACS, were transplanted into laboratory mice with acute myocardial infarction, the researchers found that the cells were engrafted in mouse hearts effectively, and their cardiac functions were improved.
Furthermore, the group also succeeded in purifying and collecting insulin-producing cells using the miR-switch-MACS. This method can be applied to a variety of cell types and is expected to supply large amounts of highly purified target cells in a short period of time for cell transplantation therapy.
The results of this study were published online in Stem Cell Reports on June 10, 2022 (Japan time).
- Journal: Stem Cell Reports
- Title: Purification of human iPSC-derived cells at large scale using microRNA switch and magnetic-activated cell sorting
- Authors: Yuta Tsujisaka1,2, Takeshi Hatani1,2, Chikako Okubo1, Ryo Ito1, Azuma Kimura1, Megumi Narita1, Kazuhisa Chonabayashi1,3, Shunsuke Funakoshi1,4, Antonio Lucena-Cacace1, Taro Toyoda1, Kenji Osafune1, Takeshi Kimura2, Hirohide Saito1, and Yoshinori Yoshida1,4
- Author Affiliations:
- Center for iPS Cell Research and Application (CiRA), Kyoto University
- Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University
- Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University
- Takeda-CiRA Joint Program (T-CiRA)